Thus, the WHO acknowledges that two diagnoses are required towards the safe and effective radical treatment of malaria: the presence of P. vivax parasites and G6PD deficiency status [2]. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.